Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Otolaryngology | Pulmonary/Respiratory Diseases | Immunology/Infectious Diseases
Disease Category: Pneumonia
Trial Information
Have you or someone you know been recently diagnosed with Idiopathic Pulmonary Fibrosis (IPF) or Usual Interstitial Pneumonia (UIP). If so, please contact Crystal Nagle at 610-988-4308 and see if this study might be for you.
This study is to determine if the drug Ambrisentan is effective in delaying disease progression and increasing quality of life and dyspena symptoms among patients.
Patient Inclusion Criteria:
- Patients 40-80 years of age.
- Diagnosis of IPF or UIP.
Patient Exclusion Criteria:
- History of Obstructive Lung Disease.
- Severe chronic Heart Failure.
- Abnormal liver function tests.
- Patients requiring dialysis.
- History of cancer within the last 5 years.
- Recent history of alcohol abuse.
- Patients who are pregnant or breast feeding.
Crystal Nagle, Clinical Trials Administrator
The Reading Hospital and Medical Center Clinical Trials Office
Sixth Ave and Spruce Street, R-Building, 4th Floor
West Reading, PA 19611
Phone: 610-988-4308
Fax: 610-988-8334
EMail: naglec@readinghospital.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
